CD44 and neoplasm: However, a direct effect on tumor cells is possible as a result of the generation of low-molecular weight (LMW)-HA fragments that can compete with high-molecular weight (HMW)-HA for binding and activation of HABPs, including the HA receptors, CD44 and RHAMM (43).